Liquid Biopsies in Esophageal Adenocarcinoma: Barrett's Esophagus and Esophageal Adenocarcinoma, Searching for Reliable Diagnostic RNA Plasma-based Biomarkers
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
This study is designed to perform a explorative search of the transcriptome to detect new circulating diagnostic sensitive and specific biomarkers in patients with Barrett's esophagus or esophageal adenocarcinoma.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• Barrett's Esophagus with length \> 3cm OR esophageal adenocarcinoma histologically proven
• Adequate mental faculty, allowing to understand the proposed treatment protocol and provide informed consent
• Age over 18 years
• No other concurrent malignant disease
• No inclusion in other clinical trials interfering with the study protocol
• No concurrent chronic systemic immune or hormone therapy, except neoadjuvant chemotherapy
• Absence of any severe organ insufficiency
• No pregnancy or breast feeding
• Written informed consent
Locations
Other Locations
Belgium
University hospital Ghent
RECRUITING
Ghent
Contact Information
Primary
Piet Pattyn, MD, PhD
piet.pattyn@ugent.be
+32 9 332 1295
Backup
Annouck Philippron, MD
annouck.philippron@ugent.be
+32 9 332 1531
Time Frame
Start Date: 2016-06
Estimated Completion Date: 2027-01-31
Participants
Target number of participants: 100
Related Therapeutic Areas
Sponsors
Collaborators: Universitaire Ziekenhuizen KU Leuven
Leads: University Hospital, Ghent